Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 270

    1.

    Virus & TSE safety forum 2008.

    Robertson JS, Blümel J, Brorson K, Gröner A, Kreil TR, Ruiz S, Willkommen H.

    Biologicals. 2009 Oct;37(5):345-54. Epub 2009 Jul 30. No abstract available. PMID: 19646899 [PubMed - in process]Related articles

    2.

    Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.

    Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, Fabry L, Heldens JG, Kino Y, Kistner O, Kompier R, Makizumi K, Medema J, Mimori S, Ryan D, Schwartz R, Smith JS, Sugawara K, Trusheim H, Tsai TF, Krause R.

    Vaccine. 2009 May 14;27(22):2907-13. Epub 2009 Feb 27. Review.PMID: 19366582 [PubMed - indexed for MEDLINE]Related articles

    3.

    Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

    Harvey R, Wheeler JX, Wallis CL, Robertson JS, Engelhardt OG.

    Vaccine. 2008 Dec 2;26(51):6550-4.PMID: 18840494 [PubMed - indexed for MEDLINE]Related articles

    4.

    WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007.

    Joung J, Robertson JS, Griffiths E, Knezevic I; WHO Informal Consultation Group.

    Biologicals. 2008 Jul;36(4):269-76. Epub 2008 Jan 22.PMID: 18218324 [PubMed - indexed for MEDLINE]Related articles

    5.

    Reference viruses for seasonal and pandemic influenza vaccine preparation.

    Wood JS, Robertson JS.

    Influenza Other Respi Viruses. 2007 Jan;1(1):5-9. Review.PMID: 19459278 [PubMed - indexed for MEDLINE]Related articles

    6.

    The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.

    Ramjanee S, Robertson JS, Franke-Fayard B, Sinha R, Waters AP, Janse CJ, Wu Y, Blagborough AM, Saul A, Sinden RE.

    Vaccine. 2007 Jan 15;25(5):886-94. Epub 2006 Sep 20.PMID: 17049690 [PubMed - indexed for MEDLINE]Related articles

    7.

    Assuring the quality, safety, and efficacy of DNA vaccines.

    Robertson JS, Griffiths E.

    Methods Mol Med. 2006;127:363-74. Review.PMID: 16988466 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bovine serum--regulatory issues.

    Robertson JS.

    Dev Biol (Basel). 2006;123:269-72; discussion 291-308.PMID: 16566452 [PubMed - indexed for MEDLINE]Related articles

    9.

    Changes in biological source material.

    Robertson JS.

    Biologicals. 2006 Mar;34(1):61-3. Epub 2005 Dec 2. Review.PMID: 16330224 [PubMed - indexed for MEDLINE]Related articles

    10.

    Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

    Nicolson C, Major D, Wood JM, Robertson JS.

    Vaccine. 2005 Apr 22;23(22):2943-52.PMID: 15780743 [PubMed - indexed for MEDLINE]Related articles

    11.

    From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

    Wood JM, Robertson JS.

    Nat Rev Microbiol. 2004 Oct;2(10):842-7. Review.PMID: 15378048 [PubMed - indexed for MEDLINE]Related articles

    12.

    The repetitive landscape of the chicken genome.

    Wicker T, Robertson JS, Schulze SR, Feltus FA, Magrini V, Morrison JA, Mardis ER, Wilson RK, Peterson DG, Paterson AH, Ivarie R.

    Genome Res. 2005 Jan;15(1):126-36. Epub 2004 Jul 15.PMID: 15256510 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Viruses and assuring viral safety.

    Robertson JS.

    Dev Biol (Basel). 2003;113:73-7. No abstract available. PMID: 14620855 [PubMed - indexed for MEDLINE]Related articles

    14.

    Preparation of vaccines against H5N1 influenza.

    Wood JM, Major D, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC.

    Vaccine. 2002 May 15;20 Suppl 2:S84-7.PMID: 12110267 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Differences in receptor specificity between the influenza A viruses isolated from the duck, chicken, and human]

    Gambarian AS, Iamnikova SS, L'vov DK, Robertson JS, Webster RG, Matrosovich MN.

    Mol Biol (Mosk). 2002 May-Jun;36(3):542-9. Russian. PMID: 12068641 [PubMed - indexed for MEDLINE]Related articles

    16.

    Retroviral aspects of the characterisation of avian and mammalian cell substrates.

    Robertson JS.

    Dev Biol (Basel). 2001;106:417-22; discussion 422-4, 465-75.PMID: 11761257 [PubMed - indexed for MEDLINE]Related articles

    17.

    European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements.

    Robertson JS, Cichutek K.

    Dev Biol (Basel). 2000;104:53-6.PMID: 11713824 [PubMed - indexed for MEDLINE]Related articles

    18.

    Assuring the quality, safety, and efficacy of DNA vaccines.

    Robertson JS, Griffiths E.

    Mol Biotechnol. 2001 Feb;17(2):143-9. Review.PMID: 11395863 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vaccines against H5N1 influenza.

    Wood JM, Major D, Daly J, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC, Lee-Lin YN.

    Vaccine. 1999 Nov 12;18(7-8):579-80. No abstract available. PMID: 10660430 [PubMed - indexed for MEDLINE]Related articles

    20.

    The influence of the host cell on standardisation of influenza vaccine potency.

    Wood JM, Dunleavy U, Newman RW, Riley AM, Robertson JS, Minor PD.

    Dev Biol Stand. 1999;98:183-8; discussion 197.PMID: 10494972 [PubMed - indexed for MEDLINE]Related articles

    21.

    An overview of host cell selection.

    Robertson JS.

    Dev Biol Stand. 1999;98:7-11; discussion 73-4. Review.PMID: 10494955 [PubMed - indexed for MEDLINE]Related articles

    22.

    A modern malaise.

    Robertson JS.

    Public Health. 1999 Jul;113(4):155-6. No abstract available. PMID: 10483074 [PubMed - indexed for MEDLINE]Related articles

    23.

    Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.

    Castle P, Robertson JS.

    Dev Biol Stand. 1999;99:191-6. Review. No abstract available. PMID: 10404890 [PubMed - indexed for MEDLINE]Related articles

    24.

    Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. 5-6 May 1998, Strasbourg, France.

    Castle P, Robertson JS.

    Biologicals. 1998 Dec;26(4):365-8. No abstract available. PMID: 10403041 [PubMed - indexed for MEDLINE]Related articles

    25.

    Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses.

    Gambaryan AS, Robertson JS, Matrosovich MN.

    Virology. 1999 Jun 5;258(2):232-9.PMID: 10366560 [PubMed - indexed for MEDLINE]Related articles

    26.

    MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

    Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber DA, Brill AB.

    J Nucl Med. 1999 Feb;40(2):37S-61S.PMID: 10025848 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.

    Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, Erdi AK, Aydogan B, Costes S, Watson EE, Brill AB, Charkes ND, Fisher DR, Hays MT, Thomas SR.

    J Nucl Med. 1999 Jan;40(1):11S-36S.PMID: 9935083 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The MIRD perspective 1999. Medical Internal Radiation Dose Committee.

    Howell RW, Wessels BW, Loevinger R, Watson EE, Bolch WE, Brill AB, Charkes ND, Fisher DR, Hays MT, Robertson JS, Siegel JA, Thomas SR.

    J Nucl Med. 1999 Jan;40(1):3S-10S.PMID: 9935082 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    International standardization of gene amplification technology.

    Robertson JS.

    Biologicals. 1998 Jun;26(2):111-3.PMID: 9811515 [PubMed - indexed for MEDLINE]Related articles

    30.

    Direct sequencing of the HA gene of clinical equine H3N8 influenza virus and comparison with laboratory derived viruses.

    Ilobi CP, Nicolson C, Taylor J, Mumford JA, Wood JM, Robertson JS.

    Arch Virol. 1998;143(5):891-901.PMID: 9645196 [PubMed - indexed for MEDLINE]Related articles

    31.

    EPFA/NIBSC Workshop on Nucleic Acid Amplification Technology (NAT) for the detection of blood borne viruses.

    Rogers PM, Robertson JS.

    Biologicals. 1998 Mar;26(1):69-74. No abstract available. PMID: 9637751 [PubMed - indexed for MEDLINE]Related articles

    32.

    Assessing the significance of reverse transcriptase activity in chick cell-derived vaccines.

    Robertson JS, Nicolson C, Riley AM, Bentley M, Dunn G, Corcoran T, Schild GC, Minor P.

    Biologicals. 1997 Dec;25(4):403-14.PMID: 9467036 [PubMed - indexed for MEDLINE]Related articles

    33.

    Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

    Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA.

    Virology. 1997 Jun 23;233(1):224-34.PMID: 9201232 [PubMed - indexed for MEDLINE]Related articles

    35.

    Reverse transcriptase activity in vaccines derived from chick cells.

    Robertson JS, Minor P.

    Biologicals. 1996 Sep;24(3):289-90. No abstract available. PMID: 8978928 [PubMed - indexed for MEDLINE]Related articles

    36.

    Strategy for adventitious agent assays.

    Robertson JS.

    Dev Biol Stand. 1996;88:37-40. Review.PMID: 9119160 [PubMed - indexed for MEDLINE]Related articles

    37.

    Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture.

    Robertson JS, Cook P, Attwell AM, Williams SP.

    Vaccine. 1995 Nov;13(16):1583-8.PMID: 8578846 [PubMed - indexed for MEDLINE]Related articles

    38.

    A collaborative study on DNA quantitation in biological products.

    Robertson JS, Heath AB.

    Biologicals. 1995 Sep;23(3):199-205.PMID: 8527118 [PubMed - indexed for MEDLINE]Related articles

    39.

    Osteoradionecrosis of the hyoid induced by combined modality therapy for laryngeal carcinoma.

    Robertson JS, Frauenhoffer EE, Stryker J, Schaitkin B, Velkley DE, McGinn JD.

    Ear Nose Throat J. 1995 Aug;74(8):578-81.PMID: 7555876 [PubMed - indexed for MEDLINE]Related articles

    40.

    Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination.

    Robertson JS, Graves JW.

    Am J Kidney Dis. 1995 Feb;25(2):359. No abstract available. PMID: 7847367 [PubMed - indexed for MEDLINE]Related articles

    41.

    Safety considerations for nucleic acid vaccines.

    Robertson JS.

    Vaccine. 1994 Dec;12(16):1526-8. Review.PMID: 7879418 [PubMed - indexed for MEDLINE]Related articles

    42.

    Mixed populations in influenza virus vaccine strains.

    Robertson JS, Cook P, Nicolson C, Newman R, Wood JM.

    Vaccine. 1994 Nov;12(14):1317-22.PMID: 7856297 [PubMed - indexed for MEDLINE]Related articles

    43.

    Antigenic and molecular characterization of host cell-mediated variants of equine H3N8 influenza viruses.

    Ilobi CP, Henfrey R, Robertson JS, Mumford JA, Erasmus BJ, Wood JM.

    J Gen Virol. 1994 Mar;75 ( Pt 3):669-73.PMID: 8126465 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    IABS International Meeting on Genetic Stability and Recombinant Product Consistency. 8-9 July, 1993, Imperial Palace Congress Centre, Annecy, France.

    Horaud F, Lubiniecki AS, Robertson JS.

    Biologicals. 1994 Mar;22(1):77-81. No abstract available. PMID: 8068318 [PubMed - indexed for MEDLINE]Related articles

    45.

    Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation.

    Gubareva LV, Wood JM, Meyer WJ, Katz JM, Robertson JS, Major D, Webster RG.

    Virology. 1994 Feb 15;199(1):89-97.PMID: 8116258 [PubMed - indexed for MEDLINE]Related articles

    46.

    Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--non-human viral transmission.

    Robertson JS.

    Ann Hematol. 1994;68 Suppl 3:S81-2. No abstract available. PMID: 8180263 [PubMed - indexed for MEDLINE]Related articles

    47.

    Polymerase chain reaction (PCR) and sequencing.

    Robertson JS.

    Dev Biol Stand. 1994;83:81-5.PMID: 7883102 [PubMed - indexed for MEDLINE]Related articles

    48.

    The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses.

    Robertson JS, Nicolson C, Major D, Robertson EW, Wood JM.

    J Gen Virol. 1993 Oct;74 ( Pt 10):2047-51.PMID: 8409929 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Analysis of the restriction to the growth of nonegg-adapted human influenza virus in eggs.

    Williams SP, Robertson JS.

    Virology. 1993 Oct;196(2):660-5.PMID: 8372439 [PubMed - indexed for MEDLINE]Related articles

    50.

    Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.

    Meyer WJ, Wood JM, Major D, Robertson JS, Webster RG, Katz JM.

    Virology. 1993 Sep;196(1):130-7.PMID: 8356790 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...